Aílton Melo

3.0k total citations
114 papers, 2.2k citations indexed

About

Aílton Melo is a scholar working on Neurology, Psychiatry and Mental health and Epidemiology. According to data from OpenAlex, Aílton Melo has authored 114 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Neurology, 24 papers in Psychiatry and Mental health and 22 papers in Epidemiology. Recurrent topics in Aílton Melo's work include T-cell and Retrovirus Studies (19 papers), Parkinson's Disease Mechanisms and Treatments (18 papers) and Botulinum Toxin and Related Neurological Disorders (17 papers). Aílton Melo is often cited by papers focused on T-cell and Retrovirus Studies (19 papers), Parkinson's Disease Mechanisms and Treatments (18 papers) and Botulinum Toxin and Related Neurological Disorders (17 papers). Aílton Melo collaborates with scholars based in Brazil, Portugal and France. Aílton Melo's co-authors include Ana Caline Nóbrega, Larissa Monteiro, Bernardo Rodrigues, Marília Sampaio, Rita Lucena, Irênio Gomes, Ramon dos Santos El-Bachá, Diêgo M. de Oliveira, Martins Dias de Cerqueira and Nildo Manoel da Silva Ribeiro and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Science of The Total Environment and American Journal of Epidemiology.

In The Last Decade

Aílton Melo

105 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aílton Melo Brazil 28 665 507 438 431 345 114 2.2k
Péter Urbán Germany 23 832 1.3× 255 0.5× 223 0.5× 98 0.2× 194 0.6× 138 2.0k
Érica Leandro Marciano Vieira Brazil 31 248 0.4× 445 0.9× 509 1.2× 64 0.1× 261 0.8× 188 3.3k
Aristo Vojdani United States 34 411 0.6× 599 1.2× 264 0.6× 56 0.1× 332 1.0× 152 3.9k
Michael Adena Australia 19 1.5k 2.3× 470 0.9× 340 0.8× 49 0.1× 252 0.7× 57 2.9k
Alexander P. Auchus United States 21 422 0.6× 730 1.4× 315 0.7× 48 0.1× 593 1.7× 47 2.3k
Lenin Pavón Mexico 27 111 0.2× 465 0.9× 289 0.7× 39 0.1× 468 1.4× 105 3.1k
Abhijit Chaudhuri United Kingdom 26 926 1.4× 924 1.8× 215 0.5× 21 0.0× 928 2.7× 63 3.9k
Paul Scully Ireland 25 65 0.1× 481 0.9× 1.1k 2.5× 75 0.2× 352 1.0× 72 5.2k
Handan Çamdeviren Türkiye 24 452 0.7× 104 0.2× 182 0.4× 53 0.1× 395 1.1× 74 1.9k
Sung Won Chae South Korea 28 130 0.2× 49 0.1× 288 0.7× 119 0.3× 174 0.5× 144 2.4k

Countries citing papers authored by Aílton Melo

Since Specialization
Citations

This map shows the geographic impact of Aílton Melo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aílton Melo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aílton Melo more than expected).

Fields of papers citing papers by Aílton Melo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aílton Melo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aílton Melo. The network helps show where Aílton Melo may publish in the future.

Co-authorship network of co-authors of Aílton Melo

This figure shows the co-authorship network connecting the top 25 collaborators of Aílton Melo. A scholar is included among the top collaborators of Aílton Melo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aílton Melo. Aílton Melo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Melo, Aílton, et al.. (2025). GLP-1 receptor agonists for the treatment of obesity in children and adolescents: a meta-analysis of randomized controlled trials. Pediatric Research. 99(2). 502–510. 3 indexed citations
2.
Melo, Aílton, et al.. (2023). Right hemisphere and metaphor comprehension: A connectionist perspective. Neuropsychologia. 187. 108618–108618. 1 indexed citations
3.
Monteiro, Larissa, et al.. (2023). Prevalence of temporomandibular disorders in the Brazilian population: A systematic review and meta-analysis. CRANIO®. 43(4). 629–636. 8 indexed citations
4.
Monteiro, Larissa, et al.. (2023). Communication disorders in the correctional system: a systematic review. SHILAP Revista de lepidopterología. 25(2). 70–79. 2 indexed citations
5.
Melo, Aílton, et al.. (2022). Body structure/function impairments and activity limitations of post-stroke that predict social participation: a systematic review. Topics in Stroke Rehabilitation. 30(6). 589–602. 12 indexed citations
6.
Lins-Kusterer, Liliane, et al.. (2021). Mortality and Morbidity Among Persons Deprived of Liberty During the COVID-19 Pandemic in Brazil. Health Equity. 5(1). 534–535. 1 indexed citations
7.
Monteiro, Larissa, et al.. (2021). Hemisphere stroke: impact on the semantic lexical aspects of language. Clinical Neurology and Neurosurgery. 207. 106722–106722. 1 indexed citations
8.
Melo, Aílton, et al.. (2020). Spasticity distribution and severity in individuals with HTLV-1-associated myelopathy/tropical spastic paraparesis. Journal of NeuroVirology. 27(6). 857–863. 1 indexed citations
9.
Melo, Aílton, et al.. (2017). PERIPHERAL POLYNEUROPATHY IN IDIOPATHIC PARKINSON’S DISEASE WITH ORAL LEVODOPA: PREVALENCE AND ASSOCIATED FACTORS. 21(2). 1 indexed citations
10.
Aguiar, Paula Fernandes de, et al.. (2014). Rivastigmine Transdermal Patch and Physical Exercises for Alzheimer’s Disease: A Randomized Clinical Trial. Current Alzheimer Research. 11(6). 532–537. 21 indexed citations
12.
Menzel, Hans-Joachim, et al.. (2010). CORRELATION BETWEEN CLINICAL AND LABORATORIAL MEASUREMENT OF HAMSTRING FLEXIBILITY. ISBS - Conference Proceedings Archive. 1(1). 1 indexed citations
13.
Melo, Aílton, et al.. (2010). Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine. Clinical Neurology and Neurosurgery. 112(6). 463–466. 55 indexed citations
14.
Nóbrega, Ana Caline, Bernardo Rodrigues, & Aílton Melo. (2009). Does botulinum toxin injection in parotid glands interfere with the swallowing dynamics of Parkinson's disease patients?. Clinical Neurology and Neurosurgery. 111(5). 430–432. 17 indexed citations
15.
Nóbrega, Ana Caline, Bernardo Rodrigues, & Aílton Melo. (2008). Is silent aspiration a risk factor for respiratory infection in Parkinson's disease patients?. Parkinsonism & Related Disorders. 14(8). 646–648. 60 indexed citations
16.
Nóbrega, Ana Caline, Bernardo Rodrigues, & Aílton Melo. (2007). Silent aspiration in Parkinson's disease patients with diurnal sialorrhea. Clinical Neurology and Neurosurgery. 110(2). 117–119. 31 indexed citations
17.
Lucena, Rita, et al.. (2005). Intra-hospital lethality among infants with pyogenic meningitis. Pediatric Neurology. 32(3). 180–183. 4 indexed citations
18.
Queirós, Fernanda C., et al.. (2004). Prognóstico audiológico tardio relacionado à meningite em lactentes. Arquivos de Neuro-Psiquiatria. 62(3a). 635–640. 6 indexed citations
19.
Lucena, Rita, Sérgio Souza da Cunha, Inês Dourado, et al.. (2002). Clinical and laboratory features of aseptic meningitis associated with measles-mumps-rubella vaccine. Revista Panamericana de Salud Pública. 12(4). 258–61. 3 indexed citations
20.
Neva, Franklin A., et al.. (1998). Interferon‐γ and Interleukin‐4 Responses in Relation to Serum IgE Levels in Persons Infected with Human T Lymphotropic Virus Type I andStrongyloides stercoralis. The Journal of Infectious Diseases. 178(6). 1856–1859. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026